Autosomal recessive juvenile Parkinson disease 2: genes and variants
Explore variant evidence for Autosomal recessive juvenile Parkinson disease 2 across 1 analyzed protein (PRKN). Linked ClinVar records include 15 pathogenic or likely pathogenic variants, 24 variants of uncertain significance and 7 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Autosomal recessive juvenile Parkinson disease 2
PRKN: E3 ubiquitin-protein ligase parkin
Its parkin ubiquitin-ligase activity marks damaged mitochondrial proteins after PINK1 activation and helps eliminate dysfunctional mitochondria through mitophagy. Biallelic loss-of-function variants are a major cause of autosomal recessive juvenile or early-onset Parkinson disease.
15 ClinVar pathogenic / likely pathogenic and 31 uncertain variants in PRKN have source records linked to Autosomal recessive juvenile Parkinson disease 2. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Autosomal recessive juvenile Parkinson disease 2
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| PRKN C441R | 441 | RING-type 2 | Pathogenic / likely pathogenic (★★) |
| PRKN G430D | 430 | RING-type 2 | Pathogenic / likely pathogenic (★★) |
| PRKN C253Y | 253 | RING-type 1 | Pathogenic / likely pathogenic (★★) |
| PRKN G284R | 284 | RING-type 1 | Pathogenic / likely pathogenic (★★) |
| PRKN M1T | 1 | Ubiquitin-like | Pathogenic / likely pathogenic (★★) |
| PRKN V56E | 56 | Ubiquitin-like | Pathogenic / likely pathogenic (★★) |
| PRKN R42P | 42 | Ubiquitin-like | Pathogenic / likely pathogenic (★★) |
| PRKN K211N | 211 | RING-type 0 | Pathogenic / likely pathogenic (★★) |
| PRKN R275W | 275 | RING-type 1 | Pathogenic / likely pathogenic (★★) |
| PRKN R33Q | 33 | Ubiquitin-like | Pathogenic / likely pathogenic (★★) |
| PRKN G135R | 135 | Necessary for PINK1-dependent localization to mi | Pathogenic / likely pathogenic (★★) |
| PRKN M434T | 434 | RING-type 2 | Pathogenic / likely pathogenic (★) |
| PRKN C431F | 431 | RING-type 2 | Pathogenic / likely pathogenic |
| PRKN K161N | 161 | RING-type 0 | Pathogenic / likely pathogenic |
| PRKN T240R | 240 | RING-type 1 | Pathogenic / likely pathogenic |
Uncertain variants prioritized for review in Autosomal recessive juvenile Parkinson disease 2
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| PRKN M434I | 434 | RING-type 2 | Uncertain (★★) | +6: 2 other pathogenic changes within 3 positions; M434T at the same position is pathogenic; REVEL 0.775 |
Which prediction tools work for Autosomal recessive juvenile Parkinson disease 2
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- AlphaMissense: 88 out of 100
- MetaSVM: 85 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 85 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 84 out of 100
- PolyPhen-2: 84 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 83 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- REVEL: 82 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CADD: 80 out of 100
- SIFT: 77 out of 100
- DMS / MaveDB: 64 out of 100
- phyloP: 61 out of 100
- Pangolin: 46 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SpliceAI: 39 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Diseases related to Autosomal recessive juvenile Parkinson disease 2
- Ovarian cancer, also linked to PRKN
- Parkinson disease, also linked to PRKN
- Autosomal dominant Parkinson disease, also linked to PRKN
- Ovarian neoplasm, also linked to PRKN
- Lung cancer, also linked to PRKN
- Young-onset Parkinson disease, also linked to PRKN
Frequently asked questions
Which genes have records linked to Autosomal recessive juvenile Parkinson disease 2?
This view contains 1 analyzed proteins: PRKN. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 15 pathogenic or likely pathogenic variants, 24 variants of uncertain significance and 7 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 1 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 54 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center